Repurposing auranofin to treat TP53-mutated or PTEN-deleted refractory B-cell lymphoma

Jeffrey Wang; Jacqueline Wang; Elyse Lopez; Hui Guo; Hui Zhang; Yang Liu; Zhihong Chen; Shengjian Huang; Shouhao Zhou; Angela Leeming; R. J. Zhang; Dayoung Jung; Hannah Shi; Hadley Grundman; Darian Doakes; Kathleen Cui; Changying Jiang; Makhdum Ahmed; Krystle Nomie; Bingliang Fang; Michael Wang; Yixin Yao; Liang Zhang

doi:10.1038/s41408-019-0259-8

Repurposing auranofin to treat TP53-mutated or PTEN-deleted refractory B-cell lymphoma

Jeffrey Wang, Jacqueline Wang, Elyse Lopez, Hui Guo, Hui Zhang, Yang Liu, Zhihong Chen, Shengjian Huang, Shouhao Zhou, Angela Leeming, R. J. Zhang, Dayoung Jung, Hannah Shi, Hadley Grundman, Darian Doakes, Kathleen Cui, Changying Jiang, Makhdum Ahmed, Krystle Nomie, Bingliang FangMichael Wang, Yixin Yao, Liang Zhang

Research output: Contribution to journal › Letter › peer-review

21 Scopus citations

Original language	English (US)
Article number	95
Journal	Blood Cancer Journal
Volume	9
Issue number	12
DOIs	https://doi.org/10.1038/s41408-019-0259-8
State	Published - Dec 1 2019

All Science Journal Classification (ASJC) codes

Hematology
Oncology

Access to Document

10.1038/s41408-019-0259-8

Cite this

Wang, J., Wang, J., Lopez, E., Guo, H., Zhang, H., Liu, Y., Chen, Z., Huang, S., Zhou, S., Leeming, A., Zhang, R. J., Jung, D., Shi, H., Grundman, H., Doakes, D., Cui, K., Jiang, C., Ahmed, M., Nomie, K., ... Zhang, L. (2019). Repurposing auranofin to treat TP53-mutated or PTEN-deleted refractory B-cell lymphoma. Blood Cancer Journal, 9(12), Article 95. https://doi.org/10.1038/s41408-019-0259-8

@article{75efda6af3884bad9a7d69368cf4f595,

title = "Repurposing auranofin to treat TP53-mutated or PTEN-deleted refractory B-cell lymphoma",

author = "Jeffrey Wang and Jacqueline Wang and Elyse Lopez and Hui Guo and Hui Zhang and Yang Liu and Zhihong Chen and Shengjian Huang and Shouhao Zhou and Angela Leeming and Zhang, {R. J.} and Dayoung Jung and Hannah Shi and Hadley Grundman and Darian Doakes and Kathleen Cui and Changying Jiang and Makhdum Ahmed and Krystle Nomie and Bingliang Fang and Michael Wang and Yixin Yao and Liang Zhang",

year = "2019",

month = dec,

day = "1",

doi = "10.1038/s41408-019-0259-8",

language = "English (US)",

volume = "9",

journal = "Blood Cancer Journal",

issn = "2044-5385",

publisher = "Nature Publishing Group",

number = "12",

}

Wang, J, Wang, J, Lopez, E, Guo, H, Zhang, H, Liu, Y, Chen, Z, Huang, S, Zhou, S, Leeming, A, Zhang, RJ, Jung, D, Shi, H, Grundman, H, Doakes, D, Cui, K, Jiang, C, Ahmed, M, Nomie, K, Fang, B, Wang, M, Yao, Y & Zhang, L 2019, 'Repurposing auranofin to treat TP53-mutated or PTEN-deleted refractory B-cell lymphoma', Blood Cancer Journal, vol. 9, no. 12, 95. https://doi.org/10.1038/s41408-019-0259-8

TY - JOUR

T1 - Repurposing auranofin to treat TP53-mutated or PTEN-deleted refractory B-cell lymphoma

AU - Wang, Jeffrey

AU - Wang, Jacqueline

AU - Lopez, Elyse

AU - Guo, Hui

AU - Zhang, Hui

AU - Liu, Yang

AU - Chen, Zhihong

AU - Huang, Shengjian

AU - Zhou, Shouhao

AU - Leeming, Angela

AU - Zhang, R. J.

AU - Jung, Dayoung

AU - Shi, Hannah

AU - Grundman, Hadley

AU - Doakes, Darian

AU - Cui, Kathleen

AU - Jiang, Changying

AU - Ahmed, Makhdum

AU - Nomie, Krystle

AU - Fang, Bingliang

AU - Wang, Michael

AU - Yao, Yixin

AU - Zhang, Liang

PY - 2019/12/1

Y1 - 2019/12/1

UR - http://www.scopus.com/inward/record.url?scp=85075602724&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075602724&partnerID=8YFLogxK

U2 - 10.1038/s41408-019-0259-8

DO - 10.1038/s41408-019-0259-8

M3 - Letter

C2 - 31780660

AN - SCOPUS:85075602724

SN - 2044-5385

VL - 9

JO - Blood Cancer Journal

JF - Blood Cancer Journal

IS - 12

M1 - 95

ER -

Repurposing auranofin to treat TP53-mutated or PTEN-deleted refractory B-cell lymphoma

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this